Walgreens Boots Alliance Inc (WBA)

52.47
0.71 1.30
NASDAQ
Prev Close 53.18
Open 53.25
Day Low/High 52.20 / 53.45
52 Wk Low/High 43.62 / 57.05
Volume 7.74M
Exchange NASDAQ
Shares Outstanding 863.27B
Market Cap 46.21B
P/E Ratio N/A
Div & Yield N.A. (N.A)
How to 'Adapt and Overcome' Amid Fed Folly: Market Recon

How to 'Adapt and Overcome' Amid Fed Folly: Market Recon

Fed Chair Jerome Powell appears intent to reverse a near decade's worth of policy in just a couple of years.

Time to Minimize Your Tax Bill With Tax-Loss Selling

Time to Minimize Your Tax Bill With Tax-Loss Selling

Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.

Ignore Headlines on Walgreens Boots Alliance

Ignore Headlines on Walgreens Boots Alliance

Focus on facts when evaluating WBA's latest quarterly results.

Market Recon: You're Now in a Fistfight, So Stand and Fight!

Market Recon: You're Now in a Fistfight, So Stand and Fight!

The big, bad wolf showed up at the door on Wednesday, but here are ways to deal with him.

Walgreens Needs a Stronger Prescription for Gains

Walgreens Needs a Stronger Prescription for Gains

Let's take a look at the charts.

Supermarket Sweepstakes

CNBC is reporting that Kroger and Walgreens Boots Alliance  are "exploring a partnership to offer customers a new service that allows them to pick up groceries ordered online at Kroger at certain Walgreens locations..." Yes this signals that more ch...

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Focus on the Forest of Spend

Jim Cramer: Focus on the Forest of Spend

We forgot that this nation is a nation based on consumption, not on industry, on sales, not on making things.

'Death by Amazon' Greatly Exaggerated

'Death by Amazon' Greatly Exaggerated

Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid Shareholders Cheer Merger Failure, Call on CEO to 'Put House In Order'

Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.

Will Rite Aid End Up Like Blockbuster?

Will Rite Aid End Up Like Blockbuster?

After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

Rite Aid's Rotten Week: How Will It Now Compete Against Walgreens, CVS?

A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Amazon Aims to Boost Sales of Its Private Label Products This Prime Day

Prime Day 2018 is expected to generate $3.4 billion in sales, according to Coresight Research.

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Jim Cramer: Why Investing in FANG Stocks Refuses to Get Long in the Tooth

Here's to FANG for once again exciting and enthralling and defying all of the negatives.

Here's What You Need to Know on Thursday

Here's What You Need to Know on Thursday

Let's go over the market on Thursday.

Chipotle Won't Release Financial Forecasts So Investors Sell: LIVE MARKETS BLOG

Chipotle Won't Release Financial Forecasts So Investors Sell: LIVE MARKETS BLOG

Shares were down 8% Thursday.

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's Acquisition of PillPack is Harming Traditional Pharmacies

Amazon's acquisition of PillPack is hitting traditional pharmacies.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were routed Monday.

Four Cheap 'Dividend Aristocrats' to Buy Now

Four Cheap 'Dividend Aristocrats' to Buy Now

These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.

A Change in the Pattern

A Change in the Pattern

Stocks traded in a different pattern Wednesday, as big tech names dominated.

Jim Cramer: With GE It's So Difficult to Believe We Are at the Bottom

Jim Cramer: With GE It's So Difficult to Believe We Are at the Bottom

I know there's plenty of irony to go around for this once great manufacturer to be replaced in the Dow by a drug store chain.

Walgreens Boots Joins a Very Special Club

Walgreens Boots Joins a Very Special Club

Drugstore giant's charts were showing positive signs even before its inclusion in the Dow Jones Industrial Average.

End of an Era for the Dow Industrials: Market Recon

End of an Era for the Dow Industrials: Market Recon

GE is getting tossed from the index, after 111 consecutive years.

GE Loses Its Spot on the Dow and 4 Other Stories to Watch Wednesday Morning

GE Loses Its Spot on the Dow and 4 Other Stories to Watch Wednesday Morning

These are the stories pushing futures higher ahead of Wednesday's opening bell.

Walgreens Presents Best Bargain in a Decade

Walgreens Presents Best Bargain in a Decade

The drugstore chain's price to fair value has not been this favorable since the Crash of 2008-2009.

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

What Theranos' 'Massive Fraud' Can Teach Biotech Investors

Theranos, once a Silicon Valley unicorn promising investors and partners like Walgreens a simple blood-testing solution, is a cautionary tale for biotech investors.

Follow the Money -- Buy CVS

Follow the Money -- Buy CVS

Few companies can match CVS' long-term record and top-quality corporate metrics.